Analyst Jeffrey Hung from Morgan Stanley maintained a Buy rating on Disc Medicine (IRON – Research Report) and keeping the price target at $85.00. Jeffrey Hung’s rating is based on the recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback